[Enoxacin for type III A prostatitis: a clinical observation].

Abstract

OBJECTIVE:

Chronic prostatitis, especially type III A, is a common disease in adult males, for which there are quite a few therapeutic methods. This study aimed to investigate the clinical efficacy of enoxacin in the treatment of III A prostatitis.

METHODS:

We selected 198 cases of III A prostatitis with complete treatment and follow-up data from the outpatients, all treated by enoxacin injection for 1 week, followed by oral medication of enoxacin for 2 weeks. Then we evaluated the therapeutic effect based on the NIH-CPSI scores and changes in the indexes of expressed prostatic secretions (EPS).

RESULTS:

The rate of total effectiveness was 86.4%, cure 8.6% (17/198), remarkable effectiveness 58.1% (115/198), improvement 19.7% (39/198), and ineffectiveness 13.6% (27/198). Only 16 cases (8.1%) complained of transitory gastrointestinal tract discomfort and/or skin itching.

CONCLUSION:

Enoxacin has desirable efficacy and few adverse effects on type III A prostatitis.

• Authors: Zhong Chen, Xi-cai Zhou, Zhi-qiang Chen, Zhang-qun Ye, Rong-jin Deng
• Journal: Zhonghua nan ke xue = National journal of andrology (Zhonghua Nan Ke Xue) Vol. 16 Issue 3 Pg. 258-60 (Mar 2010) ISSN: 1009-3591 [Print] China
• PMID: 20369557 (Publication Type: Clinical Trial, English Abstract, Journal Article)

Chemical References

• Anti-Infective Agents
• Enoxacin

Topics

• Adult
• Anti-Infective Agents (therapeutic use)
• Chronic Disease
• Enoxacin (therapeutic use)
• Humans
• Male
• Middle Aged
• Prostatitis (drug therapy)
• Treatment Outcome
• Young Adult